AMPA Receptor Antagonists [MoA] - N0000020016

Pharmacologic Class Information

Pharmacologic Code N0000020016
Pharmacologic Name AMPA Receptor Antagonists
Pharmacologic Uses
  • non-competitive AMPA glutamate receptor antagonist
Pharmacologic Concept Mechanisms of Action - [MoA]
Pharmacologic Concept Description This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

NDC Products with AMPA Receptor Antagonists

The table contains 14 products whose active ingredient are classified under the same pharmacologic class AMPA Receptor Antagonists [MoA].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
62856-272Fycompa Non-Proprietary Name: PerampanelTabletOralEisai Inc.ACTIVE
62856-274Fycompa Non-Proprietary Name: PerampanelTabletOralEisai Inc.ACTIVE
62856-276Fycompa Non-Proprietary Name: PerampanelTabletOralEisai Inc.ACTIVE
62856-278Fycompa Non-Proprietary Name: PerampanelTabletOralEisai Inc.ACTIVE
62856-280Fycompa Non-Proprietary Name: PerampanelTabletOralEisai Inc.ACTIVE
62856-282Fycompa Non-Proprietary Name: PerampanelTabletOralEisai Inc.ACTIVE
62856-290Fycompa Non-Proprietary Name: PerampanelSuspensionOralEisai Inc.ACTIVE
69616-272Fycompa Non-Proprietary Name: PerampanelTabletOralCatalyst Pharmaceuticals, Inc.ACTIVE
69616-274Fycompa Non-Proprietary Name: PerampanelTabletOralCatalyst Pharmaceuticals, Inc.ACTIVE
69616-276Fycompa Non-Proprietary Name: PerampanelTabletOralCatalyst Pharmaceuticals, Inc.ACTIVE
69616-278Fycompa Non-Proprietary Name: PerampanelTabletOralCatalyst Pharmaceuticals, Inc.ACTIVE
69616-280Fycompa Non-Proprietary Name: PerampanelTabletOralCatalyst Pharmaceuticals, Inc.ACTIVE
69616-282Fycompa Non-Proprietary Name: PerampanelTabletOralCatalyst Pharmaceuticals, Inc.ACTIVE
69616-290Fycompa Non-Proprietary Name: PerampanelSuspensionOralCatalyst Pharmaceuticals, Inc.ACTIVE